Article | May 2, 2023

Overcoming Late-Stage API Development Bottlenecks

Source: Esteve Química

By Marti Bartra and Montserrat Monsalvatje, Esteve Química

GettyImages-941351234-Pharmaceutical_Factory_Worker_Manufacturing_Production_Sterile

It is difficult to predict, during early development, when later-stage development activities may take place. In later-stage projects, though, tasks are more well-defined — typically, it is easier to determine the necessary resources and to combine different tasks and projects utilizing shared resources. Additionally, early-stage project development often is completed by CROs focused on manufacturing small quantities of active pharmaceutical ingredient (API) very quickly. They may not consider industrial and/or GMP requirements.

But meeting aggressive development timelines often demands completing remaining process and analytical tasks in parallel, as well as compensating for any lack of information. Esteve accomplishes this by setting up core teams when we begin a project, including not only personnel from R&D, process development, analytical development, and project management — as one would expect — but also representatives from production, quality, procurement, and environmental health and safety (EHS). This allows us, through regular meetings, to identify potential issues in production, quality control, EHS, and more. This helps us maximize efficiency during transfer — key to reducing project bottlenecks and delays.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online